| Destinys Home Health Care Llc | |
| 337 Oaks Trail Ste 104, Garland, Texas 75043 | |
| (214) 321-1323 | |
| Name | Destinys Home Health Care Llc |
|---|---|
| Location | 337 Oaks Trail Ste 104, Garland, Texas |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 679244 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 75006, 75032, 75041, 75043, 75044, 75050, 75052, 75062, 75074, 75098, 75104, 75115, 75150, 75154, 75204, 75208, 75210, 75215, 75216, 75217, 75218, 75219, 75223, 75228, 75234, 75235, 75236, 75238, 75241, 75243, 75246, 75251, 75287, 76012, 76110, 76119, 76131, 76179, 76182, 76207 |
| NPI Number | 1275013385 |
| Organization Name | DESTINY'S HOME HEALTH CARE LLC |
| Address | 337 Oaks Trl Ste 104, Garland, TX 75043 |
| Phone Number | 214-321-1323 |
News Archive
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
Health ingredients Europe 2010, the global event for the nutraceutical, functional health and natural ingredients industry exceeded all expectations. The decision to take the show to Spain brought high rewards, altering the landscape of the show and bringing exhibitors from over 40 countries and registered visitors from over 100 countries.
Sanofi-aventis announced today that it has entered into a definitive agreement under which an affiliate of sanofi-aventis Canada Inc. is to acquire the assets of Canderm Pharma Inc., a privately-held leading Canadian skin care company. This agreement is consistent with the sanofi-aventis Group's global strategy to expand its consumer health care growth platform and follows on the heels of the Group's acquisition of the North American CHC company Chattem Inc. in March 2010.
Meal replacements in a medically supervised weight loss program are successful in facilitating weight loss, according to a new study conducted at the University of Kentucky. The study appears in the August 2009 issue of the Journal of the American Dietetic Association.
Attorney Keith Jensen of the Fort Worth, Texas-based law firm of Jensen, Belew & Gonzalez is announcing a $3.78 million settlement with pharmaceutical manufacturer Pfizer Inc. on behalf of the family of a nine-year-old New York girl who died in June 2004 as the result of a drug-induced disease known as Stevens Johnson Syndrome, which caused all of her skin to peel off.
› Verified 3 days ago
| NPI Number | 1417494204 |
| Organization Name | DEFAITH HOME HEALTH AGENCY INC |
| Address | 2331 Gus Thomasson Rd, Ste 137, Dallas, TX 75228 |
| Phone Number | 469-684-2105 |
News Archive
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
Health ingredients Europe 2010, the global event for the nutraceutical, functional health and natural ingredients industry exceeded all expectations. The decision to take the show to Spain brought high rewards, altering the landscape of the show and bringing exhibitors from over 40 countries and registered visitors from over 100 countries.
Sanofi-aventis announced today that it has entered into a definitive agreement under which an affiliate of sanofi-aventis Canada Inc. is to acquire the assets of Canderm Pharma Inc., a privately-held leading Canadian skin care company. This agreement is consistent with the sanofi-aventis Group's global strategy to expand its consumer health care growth platform and follows on the heels of the Group's acquisition of the North American CHC company Chattem Inc. in March 2010.
Meal replacements in a medically supervised weight loss program are successful in facilitating weight loss, according to a new study conducted at the University of Kentucky. The study appears in the August 2009 issue of the Journal of the American Dietetic Association.
Attorney Keith Jensen of the Fort Worth, Texas-based law firm of Jensen, Belew & Gonzalez is announcing a $3.78 million settlement with pharmaceutical manufacturer Pfizer Inc. on behalf of the family of a nine-year-old New York girl who died in June 2004 as the result of a drug-induced disease known as Stevens Johnson Syndrome, which caused all of her skin to peel off.
› Verified 3 days ago
| NPI Number | 1841284981 |
| Organization Name | DESTINYS HOME HEALTH CARE |
| Address | 2331 Gus Thomasson Rd, Suite 137, Dallas, TX 75228 |
| Phone Number | 214-321-1323 |
News Archive
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
Health ingredients Europe 2010, the global event for the nutraceutical, functional health and natural ingredients industry exceeded all expectations. The decision to take the show to Spain brought high rewards, altering the landscape of the show and bringing exhibitors from over 40 countries and registered visitors from over 100 countries.
Sanofi-aventis announced today that it has entered into a definitive agreement under which an affiliate of sanofi-aventis Canada Inc. is to acquire the assets of Canderm Pharma Inc., a privately-held leading Canadian skin care company. This agreement is consistent with the sanofi-aventis Group's global strategy to expand its consumer health care growth platform and follows on the heels of the Group's acquisition of the North American CHC company Chattem Inc. in March 2010.
Meal replacements in a medically supervised weight loss program are successful in facilitating weight loss, according to a new study conducted at the University of Kentucky. The study appears in the August 2009 issue of the Journal of the American Dietetic Association.
Attorney Keith Jensen of the Fort Worth, Texas-based law firm of Jensen, Belew & Gonzalez is announcing a $3.78 million settlement with pharmaceutical manufacturer Pfizer Inc. on behalf of the family of a nine-year-old New York girl who died in June 2004 as the result of a drug-induced disease known as Stevens Johnson Syndrome, which caused all of her skin to peel off.
› Verified 3 days ago
| Quality Rating: |
News Archive
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
Health ingredients Europe 2010, the global event for the nutraceutical, functional health and natural ingredients industry exceeded all expectations. The decision to take the show to Spain brought high rewards, altering the landscape of the show and bringing exhibitors from over 40 countries and registered visitors from over 100 countries.
Sanofi-aventis announced today that it has entered into a definitive agreement under which an affiliate of sanofi-aventis Canada Inc. is to acquire the assets of Canderm Pharma Inc., a privately-held leading Canadian skin care company. This agreement is consistent with the sanofi-aventis Group's global strategy to expand its consumer health care growth platform and follows on the heels of the Group's acquisition of the North American CHC company Chattem Inc. in March 2010.
Meal replacements in a medically supervised weight loss program are successful in facilitating weight loss, according to a new study conducted at the University of Kentucky. The study appears in the August 2009 issue of the Journal of the American Dietetic Association.
Attorney Keith Jensen of the Fort Worth, Texas-based law firm of Jensen, Belew & Gonzalez is announcing a $3.78 million settlement with pharmaceutical manufacturer Pfizer Inc. on behalf of the family of a nine-year-old New York girl who died in June 2004 as the result of a drug-induced disease known as Stevens Johnson Syndrome, which caused all of her skin to peel off.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 76.2 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 79.8 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 98.8 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 48.4 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 86.2 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 94.1 | 96.4 |
News Archive
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
Health ingredients Europe 2010, the global event for the nutraceutical, functional health and natural ingredients industry exceeded all expectations. The decision to take the show to Spain brought high rewards, altering the landscape of the show and bringing exhibitors from over 40 countries and registered visitors from over 100 countries.
Sanofi-aventis announced today that it has entered into a definitive agreement under which an affiliate of sanofi-aventis Canada Inc. is to acquire the assets of Canderm Pharma Inc., a privately-held leading Canadian skin care company. This agreement is consistent with the sanofi-aventis Group's global strategy to expand its consumer health care growth platform and follows on the heels of the Group's acquisition of the North American CHC company Chattem Inc. in March 2010.
Meal replacements in a medically supervised weight loss program are successful in facilitating weight loss, according to a new study conducted at the University of Kentucky. The study appears in the August 2009 issue of the Journal of the American Dietetic Association.
Attorney Keith Jensen of the Fort Worth, Texas-based law firm of Jensen, Belew & Gonzalez is announcing a $3.78 million settlement with pharmaceutical manufacturer Pfizer Inc. on behalf of the family of a nine-year-old New York girl who died in June 2004 as the result of a drug-induced disease known as Stevens Johnson Syndrome, which caused all of her skin to peel off.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 49.9 | 79.6 |
| How often patients got better at getting in and out of bed | 69.2 | 81.1 |
| How often patients got better at bathing | 74.9 | 82.3 |
| How often patients’ breathing improved | 42.9 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 76 | 75 |
| How often home health patients had to be admitted to the hospital | 16.3 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 12.4 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 60.7 | 94 |
News Archive
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
Health ingredients Europe 2010, the global event for the nutraceutical, functional health and natural ingredients industry exceeded all expectations. The decision to take the show to Spain brought high rewards, altering the landscape of the show and bringing exhibitors from over 40 countries and registered visitors from over 100 countries.
Sanofi-aventis announced today that it has entered into a definitive agreement under which an affiliate of sanofi-aventis Canada Inc. is to acquire the assets of Canderm Pharma Inc., a privately-held leading Canadian skin care company. This agreement is consistent with the sanofi-aventis Group's global strategy to expand its consumer health care growth platform and follows on the heels of the Group's acquisition of the North American CHC company Chattem Inc. in March 2010.
Meal replacements in a medically supervised weight loss program are successful in facilitating weight loss, according to a new study conducted at the University of Kentucky. The study appears in the August 2009 issue of the Journal of the American Dietetic Association.
Attorney Keith Jensen of the Fort Worth, Texas-based law firm of Jensen, Belew & Gonzalez is announcing a $3.78 million settlement with pharmaceutical manufacturer Pfizer Inc. on behalf of the family of a nine-year-old New York girl who died in June 2004 as the result of a drug-induced disease known as Stevens Johnson Syndrome, which caused all of her skin to peel off.
› Verified 3 days ago
News Archive
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
Health ingredients Europe 2010, the global event for the nutraceutical, functional health and natural ingredients industry exceeded all expectations. The decision to take the show to Spain brought high rewards, altering the landscape of the show and bringing exhibitors from over 40 countries and registered visitors from over 100 countries.
Sanofi-aventis announced today that it has entered into a definitive agreement under which an affiliate of sanofi-aventis Canada Inc. is to acquire the assets of Canderm Pharma Inc., a privately-held leading Canadian skin care company. This agreement is consistent with the sanofi-aventis Group's global strategy to expand its consumer health care growth platform and follows on the heels of the Group's acquisition of the North American CHC company Chattem Inc. in March 2010.
Meal replacements in a medically supervised weight loss program are successful in facilitating weight loss, according to a new study conducted at the University of Kentucky. The study appears in the August 2009 issue of the Journal of the American Dietetic Association.
Attorney Keith Jensen of the Fort Worth, Texas-based law firm of Jensen, Belew & Gonzalez is announcing a $3.78 million settlement with pharmaceutical manufacturer Pfizer Inc. on behalf of the family of a nine-year-old New York girl who died in June 2004 as the result of a drug-induced disease known as Stevens Johnson Syndrome, which caused all of her skin to peel off.
› Verified 3 days ago
Dove Home Care Llc Location: 1919 S Shiloh Road Suite 610 Lb 17, Garland, Texas 75042 Ratings: NA Phone: (972) 864-0473 | |
Garland Home Healthcare Agency Inc Location: 3302 Blue Ridge Lane, Garland, Texas 75042 Ratings: NA Phone: (214) 876-9669 | |
Noblecare Home Health Services Inc Location: 629 West Centerville Road Suite 208, Garland, Texas 75041 Ratings: NA Phone: (972) 278-8700 | |
Glorious Home Health Care Inc Location: 329 Oaks Trail Entrance A Suite 95, Garland, Texas 75043 Ratings: NA Phone: (214) 607-4027 | |
Crest Healthcare Services Inc Location: 1111 Belt Line Rd Suite 201b, Garland, Texas 75040 Ratings: Phone: (972) 496-5252 | |
Cuddle Me Home Care Location: 310 East I-30 Suite M106, Garland, Texas 75043 Ratings: NA Phone: (469) 304-0904 |